ICCM — IceCure Medical Ltd.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1584371 ·
Israel
Last close
$2.89
Market Cap
$9.90M
52W High
$9.81
52W Low
$2.12
ADV30
1,700,270
Next earnings
2026-08-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 911,000 | 295,000 | -4,247,000 | -4,274,000 | 13,303,000 | 8,115,000 | 4,809,000 |
| Dec 2025 | 1,279,000 | 600,000 | -4,216,000 | -4,246,000 | 13,888,000 | 8,897,000 | 4,837,000 |
| Sep 2025 | 850,000 | 277,000 | -3,836,000 | -3,859,000 | 15,078,000 | 4,971,000 | 5,772,000 |
| Jun 2025 | 525,000 | 131,000 | -3,385,000 | -3,364,000 | 10,589,000 | 5,383,000 | 7,698,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-14,574,000
Investing CF
$-36,000
Financing CF
$15,834,000
CapEx
$-36,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.06
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-120,436,000
Inventory
$2,625,000
Receivables
$544,000
ST Investments
$5,034,000
EBIT TTM
$-15,094,000
Pretax Income TTM
$-15,057,000
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,565,000
EBITDA
$-15,409,000
Free Cash Flow
$-8,879,375
Enterprise Value
$-155,662
Total Cash
$8,115,000
Total Debt
$139,000
Shares Out
3,426,375
Trailing EPS
$-7.20
Book Value
$3.14
ROE
-217.2%
ROA
-80.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 3,379,000 | -15,094,000 | -15,057,000 | 13,888,000 | 4,837,000 | — | -14,574,000 |
| Dec 2024 | 3,291,000 | -15,696,000 | -15,318,000 | 12,576,000 | 5,675,000 | — | -12,563,000 |
| Dec 2023 | 3,229,000 | -15,576,000 | -14,652,000 | 16,410,000 | 4,247,000 | — | -12,550,000 |
| Dec 2022 | 3,085,000 | -16,739,000 | -16,978,000 | 30,188,000 | 4,766,000 | — | -14,292,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.51
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SINT | Sintx Technologies, Inc. | $10.81M | $1.70 | — |
| FEMY | FEMASYS INC | $8.64M | $2.86 | — |
| ALRTF | ALR Technologies SG Ltd. | $11.42M | $0.02 | — |
| HSCS | HeartSciences Inc. | $8.50M | $2.18 | — |
| DROR | Dror Ortho-Design, Inc. | $11.63M | $0.01 | — |
News headlines (Yahoo Finance, 1h cache)
IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense®
2026-07-29 12:25 · Yahoo
IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site
2026-07-27 12:32 · Yahoo
IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation
2026-07-14 12:32 · Yahoo
IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer
2026-07-06 12:11 · Yahoo
IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement
2026-06-25 12:12 · Yahoo
IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer
2026-06-23 12:10 · Yahoo
IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor
2026-06-17 17:14 · Yahoo
ICCM Stock On Track For Best Day In Nearly 5 Years — What’s Driving The 200% Rally?
2026-06-17 16:26 · Yahoo
IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance
2026-06-17 12:25 · Yahoo
IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance
2026-06-02 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.